Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grazax in children with grass pollen-induced rhinoconjunctivitis
2009-014923-22Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Dec 2009
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in allergic rhinitis (AR) and allergic conjunctivitis (AC) comparing Grazax with Placebo (2 arms). Primary endpoint: Total number of days with severe symptoms during pollen season after 3 years of treatment. Started Dec 2009; status: completed.
02
Drugs
phleum pratense allergen extract
03
Conditions
allergic rhinitis (AR)allergic conjunctivitis (AC)
Beyond the preview
Go deeper on 2009-014923-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014923-22.